Introduction
Iron-based magnetic nanoparticles (NPs) such as magnetite (Fe 3 O 4 ) have been studied in detail due to their unique properties, such as stability over time, biocompatibility, and sensitivity to magnetic field. [1] [2] [3] They can potentially be used as magnetic targeted drug delivery carriers and magnetic resonance imaging contrast agents due to their high saturation magnetization, low toxicity, and biocompatibility. 4 The magnetic properties of Fe 3 O 4 NPs are attributed to their size and size distribution, which, in turn, is dependent on the route of synthesis.
Therefore, in this study, an attempt was made to synthesize Fe 3 O 4 NPs using a safe-by-design approach by the coprecipitation method. Polyethylene glycol (PEG) was used as surfactant to control the particle size and narrow size distribution. The biocompatibility of Fe 3 O 4 NPs was evaluated by cytotoxicity assays and cell cycle analysis in the human breast adenocarcinoma cell line (MCF-7).
Materials and methods Materials
Ferric chloride hexahydrate and ferrous sulfate were purchased from SD-Fine-Chem. Ltd, Mumbai, India. Ployetheleneglycol (PEG-6000), dimethylesulphoxide, sodium hydroxide (NaOH), minimum essential medium eagle, phosphate-buffered saline, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and antibiotic-antimycotic solution were purchased from HiMedia Laboratories Pvt. Ltd., (Mumbai, India). The MCF-7 cell line was purchased from the National Centre for Cell Sciences, Pune, India.
Fe 3 O 4 Np synthesis
The preparation of Fe 3 O 4 NPs was performed by a chemical coprecipitation method of Fe 2+ and Fe 3+ ions (1:2 molar ratios) by the addition of NaOH. 5 A total volume of 15 mL of 0.25 M Fe 2+ and 0.5 M Fe 3+ solutions were prepared in deionized water. PEG was then added and the temperature slowly risen up to 80°C. During the initial 2 minutes of the reaction, NaOH was added to achieve a pH of 10. The reaction was allowed to continue on a magnetic stirrer for 2 hours. Thereafter, the suspension was centrifuged and washed several times with deionized water to lower the pH to 7. Finally, the particles were suspended in 10 mL of dimethylesulphoxide.
Characterization of Fe 3 O 4 Nps
One milliliter of the stock suspension of Fe 3 O 4 NPs was diluted in 10 mL complete minimum essential medium eagle. The hydrodynamic size and zeta potential were determined using Zetasizer Nano ZS.
Cytotoxicity assessment
The cytotoxic potential of Fe 3 O 4 NPs was assessed in MCF-7 cells after 6 and 24 hours of treatment using MTT and neutral red uptake (NRU) assays as described by Mosmann 6 and Borenfreund and Puerner, respectively. 7 
Cellular internalization of Nps
The internalization of Fe 3 O 4 NPs in MCF-7 cells was assessed according to the method described in our earlier study. 8 
Cell cycle analysis
The effect of Fe 3 O 4 NPs on cell cycle was assessed according to the method described in our earlier study. 8 
Results and discussion
The mean hydrodynamic size and zeta potential of synthesized Fe 3 O 4 NPs were 98.19±1.0 nm and 36±2 mV, respectively. Flow cytometric analysis revealed a significant (P,0.05) increase in the internalization of Fe 3 O 4 NPs in MCF-7 cells after 24 hours exposure at the two higher concentrations, as evident by an increase in the side scatter intensity (Figure 1 ).
In the cytotoxicity assays, namely NRU and MTT, Fe 3 O 4 NPs were found to be biocompatible as there was no significant increase in the NRU (88% at concentration 150 µM/mL) and a reduction (96%) in the mitochondrial succinate dehydrogenase activity was observed at the highest concentration after 24-hour exposure (Figures 2A and B) .
Additionally, no change in cell cycle progression was observed in Fe 3 O 4 NPs-treated MCF-7 cells, after 24-hour exposure (Figure 3 ).
Conclusion
Our results demonstrated that Fe 3 O 4 NPs synthesized using the safe-by-design approach showed no adverse effect on cells, as assessed by cytotoxicity assays and cell cycle analysis in MCF-7 cells, even though they are significantly 
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Biocompatible iron oxide Nps as a drug delivery vehicle internalized. Therefore, these NPs have a potential to be used as a carrier for targeted drug delivery.
